Belvedere Trading LLC Cassava Sciences Inc Call Options Transaction History

Belvedere Trading LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 09, 2024	BUY	$12.35 - $26.11 $70,395 - $148,827	5,700 Added 14.58%	44,800 $553,000
Q1 2024 May 09, 2024	BUY	$18.44 - $26.41 $520,008 - $744,762	28,200 Added 258.72%	39,100 $793,000
Q4 2023 Feb 13, 2024	BUY	$12.64 - $30.11 $10,112 - $24,088	800 Added 7.92%	10,900 $245,000
Q3 2023 Oct 27, 2023	SELL	$16.64 - $25.32 $103,168 - $156,984	-6,200 Reduced 38.04%	10,100 $168,000
Q2 2023 Aug 08, 2023	SELL	$21.59 - $27.88 $157,607 - $203,524	-7,300 Reduced 30.93%	16,300 $399,000
Q1 2023 May 15, 2023	SELL	$23.46 - $36.44 $652,188 - $1.01 Million	-27,800 Reduced 54.09%	23,600 $569,000
Q4 2022 Feb 14, 2023	BUY	$27.82 - $44.16 $1.32 Million - $2.09 Million	47,400 Added 1185.0%	51,400 $1.52 Million
Q3 2022 Oct 26, 2022	BUY	$16.33 - $51.06 $65,319 - $204,240	4,000 New	4,000 $137,000
Q1 2021 Apr 27, 2021	BUY	$7.09 - $87.95 $275,092 - $3.41 Million	38,800 New	38,800 $1.74 Million

184

13.3M

1.38M

2.04M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $1.1B
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.